V for victory | Russia approves use of Sputnik V for 60+ age group, with 90% efficacy

The Russian Ministry of Health has just approved the Sputnik V vaccine for use on people aged 60 and over, following clinical trials that showed the jab offers at least 90% efficacy for this age group.